Cargando…

Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence

Non-alcoholic fatty liver disease (NAFLD) is defined clinicopathologically by the accumulation of lipids in >5% of hepatocytes and the exclusion of secondary causes of fat accumulation. NAFLD encompasses a wide spectrum of liver damage, extending from simple steatosis or non-alcoholic fatty liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazzolini, Guillermo, Sowa, Jan-Peter, Atorrasagasti, Catalina, Kücükoglu, Özlem, Syn, Wing-Kin, Canbay, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698018/ https://www.ncbi.nlm.nih.gov/pubmed/33187255 http://dx.doi.org/10.3390/cells9112458

Ejemplares similares

SPARC expression is associated with hepatic injury in rodents and humans with non-alcoholic fatty liver disease
por: Mazzolini, Guillermo, et al.
Publicado: (2018)

4-methylumbelliferone-mediated polarization of M1 macrophages correlate with decreased hepatocellular carcinoma aggressiveness in mice
por: Rodríguez, Marcelo M., et al.
Publicado: (2021)

A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease
por: Manka, Paul P., et al.
Publicado: (2021)

Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference
por: Kozłowska-Petriczko, Katarzyna, et al.
Publicado: (2021)

Prevention of hepatocellular carcinoma and monitoring of high-risk patients
por: Kaya, Eda, et al.
Publicado: (2022)

From bedside to bench and back again—molecular mechanisms in acute liver failure
por: Sowa, Jan-Peter, et al.
Publicado: (2014)

Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice
por: Malvicini, Mariana, et al.
Publicado: (2012)

SPARC gene deletion protects against toxic liver injury and is associated to an enhanced proliferative capacity and reduced oxidative stress response
por: Peixoto, Estanislao, et al.
Publicado: (2016)

Immunotherapy for liver tumors: present status and future prospects
por: Matar, Pablo, et al.
Publicado: (2009)

Higher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure
por: Anastasiou, Olympia, et al.
Publicado: (2015)

Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide
por: Malvicini, Mariana, et al.
Publicado: (2012)

Infliximab and Dexamethasone Attenuate the Ductular Reaction in Mice
por: Verhulst, Stefaan, et al.
Publicado: (2016)

l-Ornithine l-Aspartate (LOLA) as a Novel Approach for Therapy of Non-alcoholic Fatty Liver Disease
por: Canbay, Ali, et al.
Publicado: (2019)

Macrophage Depletion Attenuates Extracellular Matrix Deposition and Ductular Reaction in a Mouse Model of Chronic Cholangiopathies
por: Best, Jan, et al.
Publicado: (2016)

Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells
por: Fiore, Esteban, et al.
Publicado: (2016)

Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis
por: Sydor, Svenja, et al.
Publicado: (2017)

Acceleration of TAA-Induced Liver Fibrosis by Stress Exposure Is Associated with Upregulation of Nerve Growth Factor and Glycopattern Deviations
por: Atorrasagasti, Catalina, et al.
Publicado: (2021)

A PDGFRβ-based score predicts significant liver fibrosis in patients with chronic alcohol abuse, NAFLD and viral liver disease
por: Lambrecht, Joeri, et al.
Publicado: (2019)

Chromatographic Scalable Method to Isolate Engineered Extracellular Vesicles Derived from Mesenchymal Stem Cells for the Treatment of Liver Fibrosis in Mice
por: Domínguez, Luciana M., et al.
Publicado: (2023)

Influence of the Bile Acid Transporter Genes ABCB4, ABCB8, and ABCB11 and the Farnesoid X Receptor on the Response to Ursodeoxycholic Acid in Patients with Nonalcoholic Steatohepatitis
por: Kreimeyer, Henriette, et al.
Publicado: (2023)

Hepatic SPARC Expression Is Associated with Inflammasome Activation during the Progression of Non-Alcoholic Fatty Liver Disease in Both Mice and Morbidly Obese Patients
por: Onorato, Agostina M., et al.
Publicado: (2023)

Low Levels of Blood Lipids Are Associated with Etiology and Lethal Outcome in Acute Liver Failure
por: Manka, Paul, et al.
Publicado: (2014)

Lack of the Matricellular Protein SPARC (Secreted Protein, Acidic and Rich in Cysteine) Attenuates Liver Fibrogenesis in Mice
por: Atorrasagasti, Catalina, et al.
Publicado: (2013)

Role of Metabolism in Hepatic Stellate Cell Activation and Fibrogenesis
por: Hou, Wei, et al.
Publicado: (2018)

NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease
por: Manka, Paul, et al.
Publicado: (2020)

Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic Steatohepatitis
por: Wattacheril, Julia, et al.
Publicado: (2013)

Update of liver fibrosis and steatosis with transient elastography (Fibroscan)
por: Wong, Grace Lai-Hung
Publicado: (2013)

Periodontitis is associated with significant hepatic fibrosis in patients with non-alcoholic fatty liver disease
por: Alazawi, William, et al.
Publicado: (2017)

Proteomic screening of plasma identifies potential noninvasive biomarkers associated with significant/advanced fibrosis in patients with nonalcoholic fatty liver disease
por: Hou, Wei, et al.
Publicado: (2020)

A simple index of lipid overaccumulation is a good marker of liver steatosis
por: Bedogni, Giorgio, et al.
Publicado: (2010)

Local fat content determines global and local stiffness in livers with simple steatosis
por: Li, David, et al.
Publicado: (2023)

Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis
por: Elfimova, Natalia, et al.
Publicado: (2012)

Novel Algorithm for Non-Invasive Assessment of Fibrosis in NAFLD
por: Sowa, Jan-Peter, et al.
Publicado: (2013)

The Presence of Periodontitis Exacerbates Non-Alcoholic Fatty Liver Disease via Sphingolipid Metabolism-Associated Insulin Resistance and Hepatic Inflammation in Mice with Metabolic Syndrome
por: Lu, Zhongyang, et al.
Publicado: (2023)

Compensation of feature selection biases accompanied with improved predictive performance for binary classification by using a novel ensemble feature selection approach
por: Neumann, Ursula, et al.
Publicado: (2016)

Three Cases of Alcohol-Induced Acute-On-Chronic Liver Failure With Successful Support by Adipose-Derived Stem Cells
por: Götze, Tobias, et al.
Publicado: (2019)

Healthcare resource utilization and costs among nonalcoholic fatty liver disease patients in Germany
por: Canbay, Ali, et al.
Publicado: (2021)

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
por: Bedogni, Giorgio, et al.
Publicado: (2006)

Diagnostic and prognostic significance of hepatic steatosis in patients with chronic hepatitis C
por: Stan, Ionelia Sorina, et al.
Publicado: (2021)

Serum levels of interleukin-1 beta associate better with severity of simple steatosis than liver function tests in morbidly obese patients
por: Palomera, Leon F, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tduu6qcrm93fpld7li00bj573e